Pharmacokinetics and Pharmacodynamics
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
“Pharmacokinetics and Pharmacodynamics” is a Section of the peer-reviewed open access journal Pharmaceutics, which is devoted to highlighting the importance of pharmacokinetics and pharmacodynamics in drug development for better understanding of drug action. The Section welcomes original research articles as well as review papers that address a variety of related topics to novel and significant scientific findings by in vitro, in vivo, and clinical studies. The manuscript mainly focused on descriptive pharmacokinetics lacking novelty and scientific significance will not be considered for review.
Covered topics include:
- Mechanisms and factors affecting drug absorption, distribution, metabolism, and excretion;
- Kinetics of drug disposition and therapeutic effects;
- Pharmacokinetics, pharmacodynamics, and pharmacometrics;
- Toxicokinetics and toxicodynamics;
- Mathematical model for the assessment of drug ADME;
- Model-based drug development;
- Translational mathematical modeling in drug development;
- Quantitative systems pharmacology.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Microfluidic Vascularized Tissue Model-Based Drug Transport and Pharmacokinetics (Deadline: 20 December 2023)
- Novel Approaches for Optimizing Pharmacotherapy Based on Recent Pharmacokinetic, Pharmacodynamic, and Pharmacogenetic Developments (Deadline: 20 December 2023)
- Formulation Strategies to Optimize Drug Pharmacokinetics and Improve Therapeutic Outcomes (Deadline: 25 December 2023)
- ADME Properties in the Drug Delivery (Deadline: 30 December 2023)
- Pharmacokinetics and Drug Interactions (Deadline: 31 December 2023)
- Pharmacokinetic and Pharmacodynamic Considerations for Drugs Used in the Treatment of Cardiovascular Diseases (Deadline: 31 December 2023)
- Assessment of the Performance of Non-systemic Locally-Acting Drugs in the Gastrointestinal Tract (Deadline: 31 December 2023)
- Innovative In Vitro/In Silico Approaches to Drug Permeation and Absorption: The Highway to Implement the 3Rs Principles in Drug Development (Deadline: 20 January 2024)
- Pharmacokinetics of Orally Administered Drugs, 2nd Edition (Deadline: 31 January 2024)
- Novel Anti-cancer Compounds: Drug Metabolism and Absorption (Deadline: 31 January 2024)
- Optimizing Drug Safety and Efficacy: Pharmacokinetic Modeling (Deadline: 31 January 2024)
- Pharmacokinetics and Artificial Intelligence for Drug Predictions (Deadline: 10 February 2024)
- Recent Advances in Polymeric Nanoparticle-Based Drug Delivery System for Cancer Therapy (Deadline: 15 February 2024)
- Toxicokinetics in Renal Disease (Deadline: 20 February 2024)
- Advances in Pharmacokinetics, Pharmacodynamics and Drug Interactions, 2nd Edition (Deadline: 28 February 2024)
- In Silico Drug Testing and Optimization, Coupling Physical-Based Modeling and Machine Learning (Deadline: 29 February 2024)
- Advances in Pharmacokinetics and Drug-Drug Interactions (Deadline: 29 February 2024)
- Physiologically-Based Pharmacokinetic Modeling in Pregnancy, Lactation, and in Neonates: Achievements, Challenges and Future Directions (Deadline: 29 February 2024)
- Pharmacokinetics, Pharmacodynamics and Drug Interactions (Deadline: 15 March 2024)
- Role of Pharmacokinetics in Drug Development and Evaluation (Deadline: 20 March 2024)
- Optimization of Tuberculosis Drugs and Treatment Strategies to End Tuberculosis (TB) (Deadline: 20 March 2024)
- Dose Optimization of Traditional and New Drug Formulations in Veterinary and Human Medicine (Deadline: 30 March 2024)
- Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy, 2nd Edition (Deadline: 10 April 2024)
- Model-Informed Drug Discovery and Development, 2nd Edition (Deadline: 20 April 2024)
- Transport and Metabolism of Small-Molecule Drugs, 2nd Edition (Deadline: 20 April 2024)
- Precision Dosing in Clinical Therapeutics: The Application of Pharmacokinetics and Pharmacometrics (Deadline: 30 April 2024)
- Development of Physiologically Based Pharmacokinetic (PBPK) Modeling (Deadline: 30 April 2024)
- New Insights into Physiologically Based Pharmacokinetic Modeling (Deadline: 20 May 2024)
- Physiologically-Based Pharmacokinetics (PBPK) and Biopharmaceutics (PBBM) Modeling for Formulation Development (Deadline: 31 May 2024)